Some studies have shown that EMP3 is much lower in non-small cell lung cancer than in normal control tissue, which is connected to the TMN stage, but there is no significant correlation with other clinical parameters [137]. This evidence concerns the gene EMP3 and non-small cell lung carcinoma.